InvestorsHub Logo
Followers 210
Posts 22082
Boards Moderated 1
Alias Born 11/24/2002

Re: None

Thursday, 11/07/2019 10:48:44 AM

Thursday, November 07, 2019 10:48:44 AM

Post# of 777
We intend to use the net proceeds from this offering to fund MOMENTUM, our planned Phase 3 clinical trial of momelotinib, as well as for general corporate purposes.

and they will be doing this until the stock is at .02. for GENERAL PURPOSES means PAYING salaries duh

They call me Lazarous!